139 related articles for article (PubMed ID: 16797165)
1. Antimicrobial activities of human beta-defensins against Bacillus species.
Yadava P; Zhang C; Sun J; Hughes JA
Int J Antimicrob Agents; 2006 Aug; 28(2):132-7. PubMed ID: 16797165
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of three beta-defensins from canine testes.
Sang Y; Ortega MT; Blecha F; Prakash O; Melgarejo T
Infect Immun; 2005 May; 73(5):2611-20. PubMed ID: 15845463
[TBL] [Abstract][Full Text] [Related]
3. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.
Schroeder BO; Wu Z; Nuding S; Groscurth S; Marcinowski M; Beisner J; Buchner J; Schaller M; Stange EF; Wehkamp J
Nature; 2011 Jan; 469(7330):419-23. PubMed ID: 21248850
[TBL] [Abstract][Full Text] [Related]
4. Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin.
Bai Y; Liu S; Jiang P; Zhou L; Li J; Tang C; Verma C; Mu Y; Beuerman RW; Pervushin K
Biochemistry; 2009 Aug; 48(30):7229-39. PubMed ID: 19580334
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.
Yang M; Zhang C; Zhang X; Zhang MZ; Rottinghaus GE; Zhang S
BMC Microbiol; 2016 Sep; 16(1):210. PubMed ID: 27613063
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism.
Circo R; Skerlavaj B; Gennaro R; Amoroso A; Zanetti M
Biochem Biophys Res Commun; 2002 Apr; 293(1):586-92. PubMed ID: 12054642
[TBL] [Abstract][Full Text] [Related]
7. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.
Li T; Guo F; Wang Q; Fang H; Li Z; Wang D; Wang H
PLoS One; 2015; 10(2):e0117913. PubMed ID: 25706284
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system.
Klüver E; Adermann K; Schulz A
J Pept Sci; 2006 Apr; 12(4):243-57. PubMed ID: 16491514
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Krishnakumari V; Singh S; Nagaraj R
Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
[TBL] [Abstract][Full Text] [Related]
10. The first salamander defensin antimicrobial peptide.
Meng P; Yang S; Shen C; Jiang K; Rong M; Lai R
PLoS One; 2013; 8(12):e83044. PubMed ID: 24386139
[TBL] [Abstract][Full Text] [Related]
11. Role of acetylation and charge in antimicrobial peptides based on human beta-defensin-3.
Papanastasiou EA; Hua Q; Sandouk A; Son UH; Christenson AJ; Van Hoek ML; Bishop BM
APMIS; 2009 Jul; 117(7):492-9. PubMed ID: 19594489
[TBL] [Abstract][Full Text] [Related]
12. Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity.
Sharma H; Mathew B; Nagaraj R
J Pept Sci; 2015 Jun; 21(6):501-11. PubMed ID: 25810238
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity and structure of a consensus human β-defensin and its comparison to a novel putative hBD10.
Rodriguez A; Pedersen MØ; Villegas E; Rivas-Santiago B; Villegas-Moreno J; Amero C; Norton RS; Corzo G
Proteins; 2020 Jan; 88(1):175-186. PubMed ID: 31325337
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships in beta-defensin peptides.
Taylor K; Barran PE; Dorin JR
Biopolymers; 2008; 90(1):1-7. PubMed ID: 18041067
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.
Falanga A; Nigro E; De Biasi MG; Daniele A; Morelli G; Galdiero S; Scudiero O
Molecules; 2017 Jul; 22(7):. PubMed ID: 28726740
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of human β-defensins against lactic acid bacteria.
Wang XF; Tian F; Cao RM; Li J; Wu SM; Guo XK; Chen TX
Nat Prod Res; 2015; 29(22):2164-6. PubMed ID: 25560646
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial characterization of human beta-defensin 3 derivatives.
Hoover DM; Wu Z; Tucker K; Lu W; Lubkowski J
Antimicrob Agents Chemother; 2003 Sep; 47(9):2804-9. PubMed ID: 12936977
[TBL] [Abstract][Full Text] [Related]
18. Two arginine residues in the COOH-terminal of human β-defensin-3 constitute an essential motif for antimicrobial activity and IL-6 production.
Sakagami-Yasui Y; Shirafuji Y; Yamasaki O; Morizane S; Hamada T; Umemura H; Iwatsuki K
Exp Dermatol; 2017 Nov; 26(11):1026-1032. PubMed ID: 28418601
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.
García JR; Jaumann F; Schulz S; Krause A; Rodríguez-Jiménez J; Forssmann U; Adermann K; Klüver E; Vogelmeier C; Becker D; Hedrich R; Forssmann WG; Bals R
Cell Tissue Res; 2001 Nov; 306(2):257-64. PubMed ID: 11702237
[TBL] [Abstract][Full Text] [Related]
20. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore EV; Park CH; Quayle AJ; Wiles KR; McCray PB; Ganz T
J Clin Invest; 1998 Apr; 101(8):1633-42. PubMed ID: 9541493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
